The present study shows that a number of basic antifungal peptides, including 
human salivary histatin 5, a designed histatin analog designated dhvar4, and a 
peptide from frog skin, PGLa, are active against amphotericin B-resistant 
Candida albicans, Candida krusei, and Aspergillus fumigatus strains and against 
a fluconazole-resistant Candida glabrata isolate.